This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Heinrich-Pette-Institut Für Experimentelle Virologie Und Immunologie an Der Universität Hamburg, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Technische Universitát Dresden. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014
Title: Ilona Hauber: Innovator in Retroviral Treatment
Introduction
Ilona Hauber is a prominent inventor based in Hamburg, Germany. She has made significant contributions to the field of retroviral infections through her innovative research and patented inventions. Her work focuses on developing methods to improve treatment options for patients suffering from these infections.
Latest Patents
Ilona Hauber holds a patent for the "Use of tailored recombinases for the treatment of retroviral infections." This invention is directed towards a method for preparing an expression vector that encodes a tailored recombinase. The tailored recombinase is designed to recombine asymmetric target sites within the long terminal repeat (LTR) of proviral DNA of a retrovirus integrated into the genome of a host cell. This method is useful for excising the provirus from the host cell's genome. Additionally, her invention includes an in vitro method for optimizing the treatment of retroviral infections and the use of tailored recombinases in pharmaceutical compositions aimed at reducing viral load in infected subjects.
Career Highlights
Throughout her career, Ilona Hauber has worked with esteemed institutions such as Technische Universität Dresden and the Max Planck Society for the Advancement of Science. Her research has been pivotal in advancing the understanding and treatment of retroviral infections.
Collaborations
Ilona has collaborated with notable colleagues, including Joachim Hauber and Frank Buchholz, contributing to the collective knowledge and innovation in her field.
Conclusion
Ilona Hauber's work exemplifies the impact of innovative research on the treatment of retroviral infections. Her patented methods and collaborations highlight her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile